A prospective, randomized, multicenter, comparative and open-label study on hepatotoxicity of anastrozole compared with tamoxifen in adjuvant therapy in postmenopausal women with hormone receptor plus early breast cancer
机构：[1]The First Affiliated Hospitalof Sun Yat-Sen University, Breast Surgery, Guangzhou, China中山大学附属第一医院[2]GuangxiTumour Institute & Hospital, Nanning, China[3]The First Affiliated Hospitalof Wenzhou Medical College, Wenzhou, China[4]First Affiliated Hospitalof Dalian Medical University, Dalian, China大连医科大学附属第一医院[5]Sichuan Cancer Hospital,Chengdu, China四川省肿瘤医院[6]Fujian Provincial Tumor Hospital, Fuzhou, China[7]Second Affiliated Hospital Zhejiang University College of Medicine,Hangzhou, China[8]Yunnan Tumor Hospital, Kunming, China[9]WestChina Hospital Sichuan University, Chengdu, China[10]The First AffiliatedHospital Sun Yat-Sen University, Breast Surgery, Guangzhou, China中山大学附属第一医院
第一作者机构：[1]The First Affiliated Hospitalof Sun Yat-Sen University, Breast Surgery, Guangzhou, China
推荐引用方式(GB/T 7714)：
Y. Lin,J.L. Liu,X.H. Zhang,et al.A prospective, randomized, multicenter, comparative and open-label study on hepatotoxicity of anastrozole compared with tamoxifen in adjuvant therapy in postmenopausal women with hormone receptor plus early breast cancer[J].EUROPEAN JOURNAL OF CANCER.2013,49:S466-S466.
APA：
Y. Lin,J.L. Liu,X.H. Zhang,L. Li,R. Hu...&S.M. Wang.(2013).A prospective, randomized, multicenter, comparative and open-label study on hepatotoxicity of anastrozole compared with tamoxifen in adjuvant therapy in postmenopausal women with hormone receptor plus early breast cancer.EUROPEAN JOURNAL OF CANCER,49,
MLA：
Y. Lin,et al."A prospective, randomized, multicenter, comparative and open-label study on hepatotoxicity of anastrozole compared with tamoxifen in adjuvant therapy in postmenopausal women with hormone receptor plus early breast cancer".EUROPEAN JOURNAL OF CANCER 49.(2013):S466-S466
医学